Novocure Ltd balance sheet
At the end of fiscal 2025, Novocure Ltd had total assets of $804m, total liabilities of $464m and shareholders' equity of $340m. It held $93.5m in cash against $195m of debt.
Balance sheet
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 176 | 58 | 119 | 100 | 79 | 141 | 177 | 235 | 209 | 115 | 241 | 164 | 94 | 97 |
| Receivables | — | — | 0 | 6 | 30 | 37 | 59 | 97 | 94 | 86 | 61 | 74 | 89 | 108 |
| Inventory | — | 3 | 14 | 26 | 22 | 23 | 24 | 27 | 24 | 29 | 38 | 35 | 41 | 41 |
| Total current assets | — | 112 | 294 | 262 | 245 | 321 | 440 | 999 | 1,074 | 1,112 | 1,034 | 1,107 | 647 | 674 |
| Total assets | — | 118 | 307 | 282 | 265 | 340 | 479 | 1,052 | 1,139 | 1,192 | 1,146 | 1,241 | 804 | 829 |
| Deferred revenue (current) | — | — | — | — | — | — | — | — | — | 18 | 16 | 14 | 16 | 18 |
| Total current liabilities | — | 18 | 29 | 37 | 50 | 65 | 86 | 114 | 143 | 159 | 179 | 756 | 223 | 271 |
| Short-term debt | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 25 |
| Long-term debt | — | 0 | 23 | 96 | 97 | 149 | 149 | 430 | 562 | 566 | 569 | 97 | 195 | — |
| Total debt | 0 | 0 | 23 | 96 | 97 | 149 | 149 | 430 | 562 | 566 | 569 | 655 | 195 | 196 |
| Total liabilities | — | 20 | 57 | 140 | 152 | 228 | 262 | 575 | 729 | 750 | 784 | 881 | 464 | 478 |
| Shareholders' equity | 172 | 98 | 251 | 142 | 114 | 112 | 218 | 477 | 410 | 441 | 362 | 360 | 340 | 351 |
| Shares outstanding | — | 13m | — | 87m | 89m | 93m | 100m | 102m | 104m | 105m | 107m | 109m | 112m | 117m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 74 | 85 | 90 | 85 | 89 | 93 | 99 | 108 |
| Inventory | 35 | 39 | 40 | 39 | 41 | 43 | 42 | 41 |
| Total current assets | 1,107 | 1,089 | 1,083 | 1,200 | 647 | 632 | 639 | 674 |
| Total assets | 1,241 | 1,249 | 1,246 | 1,361 | 804 | 788 | 795 | 829 |
| Deferred revenue (current) | 14 | 15 | 15 | 16 | 16 | 16 | 17 | 18 |
| Total current liabilities | 756 | 743 | 750 | 776 | 223 | 218 | 221 | 271 |
| Short-term debt | — | — | — | — | 0 | — | — | 25 |
| Long-term debt | 97 | — | — | — | 195 | — | — | — |
| Total debt | 97 | — | — | — | 195 | — | — | 25 |
| Total liabilities | 881 | 887 | 896 | 1,020 | 464 | 457 | 457 | 478 |
| Shareholders' equity | 360 | 362 | 349 | 341 | 340 | 331 | 338 | 351 |
| Shares outstanding | 109m | 111m | 112m | 112m | 112m | 116m | 116m | 117m |
Compare with peers
- Glaukos Corp balance sheet
- Transmedics Group, Inc. balance sheet
- Myriad Genetics Inc balance sheet
- Irhythm Holdings, Inc. balance sheet
- Orthofix Medical Inc. balance sheet
Head to head: GKOS vs NVCRNVCR vs TMDXMYGN vs NVCR
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies